Science, explained as simply as possible ... but not simpler
A team of Canadian and international scientists have begun reconstructing the evolving ecology of the Yukon across several hundred thousand years. The team discovered an unusual, but informative, source of DNA : coprolites - the frozen, fossilized feces preserved in the middens of Arctic ground squirrels. The paper, published in Nature Communications, provides a unique way to study the ancient and evolving ecosystem of the Arctic.
The team used shotgun metagenomics to sequence all DNA found in the coprolite samples. Arctic ground squirrels are not fussy eaters, happily foraging for grasses, seeds, insects, and frequently scavenging from carrion. The rodents deposit their droppings in discrete middens, which first freeze and eventually fossilize, allowing for the preservation of fecal DNA for far longer than in conventional environments.
Study Findings
Thirteen coprolite samples provided an enriched source of ancient environmental DNA - the quality of which often exceeded samples from bone or sediment of similar age.
Researchers identified 200 distinct plant clades; older coprolites contained grass, plantain, sagebrush and sedge, whilst more recent samples included boreal trees like spruce, birch and alder.
All 13 samples contained DNA from large megafauna, including woolly mammoth, steppe bison, Yukon horse, and possibly the extinct American cheetah.
The study described 404 bacterial and archaea genomes not present in surrounding soil controls, suggesting they could have been part of the squirrel's gut microbiome.
The team sequenced 18 mitochondrial genomes, including the ground squirrel, snow hare, bison, and Yukon horse. They will present their woolly mammoth data in a follow-up paper.
The modern Arctic ground squirrel U.parryii replaced the Pleistocene species around 420 000 years ago. The ancient species is more closely related to the modern Eurasian ground squirrel U.undulatus.
The Bottom Line
This study establishes permafrost-preserved coprolites as a high-quality source of ancient environmental DNA, providing a clue to a changing ecological environment over time. With hundreds of ancient middens being identified in the Yukon, more samples should yield a better view of how ground squirrels, the food they ate and the microbes in their guts adapted to an evolving world over nearly 700 000 years.
Discovery of an atmosphere on a trans-Neptunian object
Astronomers in Japan have reported in Nature that a trans-Neptunian object (TNO) orbiting the Sun beyond Pluto may have an atmosphere. This is the first evidence of volatile gas on a small body such as a TNO in the outer solar system.
Statin skeptics are losing the argument
My Op-Ed, published at kevinmd.com, on two meta-analyses showing the safety and efficacy of lipid lowering therapy. Are you concerned about statins? In the past two weeks, cold hard statistics have cut through the fog of misinformation surrounding these best-selling drugs, focusing instead on the safety and efficacy of lowering your blood cholesterol level. No emotions or bias, just numbers. Welcome information for anyone who has enjoyed numerous trips around the sun and is looking forward to many more.
Read more ...
Inflammation & cardiovascular disease: the 2025 ACC Scientific Statement.
The American College of Cardiology has released a scientific statement identifying inflammation as a necessary factor in the development of cardiovascular disease (CVD). It joins the prime suspect, the apoB-containing lipid particles, as an actionable drug target in both primary and secondary populations. The college has called for the widespread adoption of high-sensitivity CRP screening to identify individuals with chronic inflammation, but normal cholesterol, who remain vulnerable to the disease. Read more ...
White Paper - MDMA & chronic pain
Chronic pain affects over 1.5 billion people globally, and is a major contributor to disability, and reduced quality of life. Prolonged opioid-based therapies come with an increased risk of addiction. A non-opioid, non-addictive analgesic is needed to circumvent the short-comings of opioid therapy in a multibillion dollar market .
A new triple drug combination therapy can extend the overall survival time for patients with breast tumours resistant to conventional chemotherapy.
A multinational clinical trial has reported that lepodisiran, a new gene silencing drug, can reduce lipoprotein(a) levels by up to 93.9% compared to placebo.